NCT02041117 (REALM) is a Phase 4 clinical trial of Rosuvastatin in Intracranial Arterial Stenosis, sponsored by Beijing Tiantan Hospital.

Who is sponsoring NCT02041117?

NCT02041117 is sponsored by Beijing Tiantan Hospital.

What drugs are being tested in NCT02041117?

Interventions in NCT02041117: Rosuvastatin.

What condition does NCT02041117 study?

NCT02041117 studies Intracranial Arterial Stenosis.

Is NCT02041117 still recruiting?

NCT02041117 is currently completed. Last updated 27 July 2020.

Last reviewed 2020-07-27 · How we verify

NCT02041117: REALM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging

Completed Phase 4 Last updated 27 July 2020

What this trial tests

Phase 4 trial testing Rosuvastatin in Intracranial Arterial Stenosis in 162 participants. Completed in 6 November 2018.

Timeline

24 February 2014

Primary endpoint
6 November 2018

6 November 2018

Quick facts

Lead sponsor	Beijing Tiantan Hospital
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	162
Start date	24 February 2014
Primary completion	6 November 2018
Estimated completion	6 November 2018
Sites	1 location across China

Drugs / interventions tested

Rosuvastatin (rosuvastatin) — full drug profile →

Conditions studied

Intracranial Arterial Stenosis — all drugs for Intracranial Arterial Stenosis →

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 18 to 75, any sex, with Intracranial Arterial Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. It is a multicenter, open-label, sing arm study to evaluate the effects of treatment of Rosuvastatin 10-20mg in volume and morphology of atherosclerotic plague by reducing LDL-C level to or less than 70mg/dl. 2. Ischemic stroke patients will be enrolled within 1 month after stroke onset. 3. Patients will be visited at 0m, 1m, 3m, 6m, 9m, 12m, 18m and 24m.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Rosuvastatin

Trials testing the same drug.

NCT07474649 — A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events · Phase 3 · not yet recruiting
NCT07534592 — A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants · Phase 1 · not yet recruiting
NCT07515339 — A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dab · Phase 1 · not yet recruiting
NCT07303816 — Statins to Prevent Cancer Associated Blood Clots · Phase 4 · not yet recruiting
NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting

Other recruiting trials for Intracranial Arterial Stenosis

Currently open trials in the same condition.

NCT07352852 — Rapamycin-Eluting Vertebral Stents In The Real-World Treatment of Symptomatic Intracranial Atherosclerotic Stenosis · recruiting
NCT05844176 — Intracranial Arterial Stenosis in Young Patients · recruiting

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

NCT07341854 — Dexamethasone Palmitate for Postoperative Pain · NA · not yet recruiting
NCT07527013 — Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke · Phase 3 · not yet recruiting
NCT07520370 — Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor · NA · not yet recruiting
NCT07526987 — Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis · Phase 3 · not yet recruiting
NCT07591207 — The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02041117 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Tiantan Hospital
Last refreshed: 27 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02041117.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing